Perceive Biotherapeutics
About:
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Website: https://perceivebio.com
Top Investors: Deerfield, Catalio Capital Management, Johnson & Johnson Innovation – JJDC, Braidwell, Retinal Degeneration Fund
Description:
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Total Funding Amount:
$78M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
South San Francisco, California, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)perceivebio.com
Founders:
Anne Rubin
Number of Employees:
1-10
Last Funding Date:
2023-01-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai